Tarsus Pharmaceuticals, Inc. TARS Lease Liability Payments - Due After Year Five
Lease Liability Payments - Due After Year Five at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s lease liability payments - due after year five.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s lease liability payments - due after year five?
- Tarsus Pharmaceuticals, Inc. (TARS) reported lease liability payments - due after year five of $15.4M in Q4 2025.
- What does lease liability payments - due after year five mean?
- Represents the total undiscounted future cash outflows required for operating and finance lease obligations beyond a five-year horizon. This metric provides visibility into long-term fixed occupancy and equipment costs, which are critical for assessing structural overhead and long-term solvency.